SERPINE2 and breast carcinoma: As LDL-mediated increase in SERPINE2 expression was reverted by using an anti-Human LDLR receptor antibody, we then tested the hypothesis that this antibody could prevent the increased intravasation capacity of breast cancer cells mediated by the high cholesterol diet in vivo.